A5218 — Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication

A5218 — Relates to designating an individual to be notified in the case of dose or brand change for psychotropic medication · Informed CitizenryThis bill amends the public health law to grant patients the right to designate an individual to be notified if a facility reduces the dose or changes the brand or form of a patient's psychotropic…Open in Informed Citizenry